Dr Geoff Hall and Professor Adam Glaser
University of Leeds and the Leeds Teaching Hospitals NHS Trust
This study seeks to examine clinical outcomes (including both overall and recurrence-free survival) through the use of routinely collected healthcare data. The data is contained within comprehensive electronic patient records from both secondary and primary care, in unselected groups of cancer patients. The study has ethical approval and aims to securely link non-identifiable information from general practice, community (primary care) and hospital electronic records.
The results of this study will provide a detailed picture of what happens to cancer patients across their cancer pathway, and the costs involved in their care. It will particularly focus on the impact of co-morbidity at diagnosis and the development of late effects following treatment. The programme will provide comprehensive intelligence applicable to the UK on cancer recurrence and consequences of the cancer and its treatment, to further inform health and social care and to support evidence-based decision-making.
The study began in October 2015 and will run for three years.Close